Longevity Peptides: Research Guide to NAD+, MOTS-c, SS-31, GHK-Cu and FOXO4-DRI

Longevity peptide research has grown substantially since 2020, driven by convergent advances in mitochondrial biology, senescence research, and NAD+ metabolism. This guide provides a research overview of the major compounds in this category, their mechanisms, published research, and how they are used in cellular ageing biology laboratory settings.

The Major Longevity Research Categories

Longevity peptide research divides into four mechanistic categories, each targeting distinct aspects of the cellular ageing process.

NAD+ metabolism — targeting the decline in cellular NAD+ levels that occurs with age, affecting sirtuin activity, PARP DNA repair capacity, and mitochondrial function.

Mitochondrial peptides — addressing mitochondrial dysfunction in ageing through mitochondria-derived signalling peptides (MOTS-c) and mitochondrial membrane-targeted compounds (SS-31 Elamipretide).

Matrix and gene expression biology — GHK-Cu, whose plasma levels decline dramatically with age and which modulates hundreds of genes including those involved in tissue maintenance and antioxidant defence.

Senescent cell biology — FOXO4-DRI, targeting the FOXO4-p53 survival mechanism that enables senescent cells to evade apoptosis.

NAD+ in Ageing Research

NAD+ decline with age is one of the most consistently documented phenomena in ageing biology across multiple species. Verdin (Science, 2015) provided a comprehensive review of NAD+ in ageing, metabolism, and neurodegeneration, establishing the mechanistic framework for most subsequent research.

The age-related NAD+ decline is driven by several factors: increased CD38 activity (a major NAD+ hydrolase whose expression rises with age and inflammation), declining NAMPT enzyme activity in some tissues, and increased PARP activity driven by accumulating DNA damage.

NAD+ is central to sirtuin function. SIRT1 regulates PGC-1alpha-mediated mitochondrial biogenesis (directly relevant to MOTS-c and SS-31 research), SIRT3 maintains mitochondrial OXPHOS efficiency, and SIRT6 supports DNA repair and telomere maintenance. When NAD+ falls, all sirtuin activity falls with it.

Research tools: NAD+ and 5-Amino-1MQ (NNMT inhibitor that redirects nicotinamide to NAD+ biosynthesis).

MOTS-c: Mitochondria-Derived Signalling

MOTS-c was identified in Cell Metabolism (Lee et al., 2015) as a peptide encoded within the mitochondrial genome's 12S rRNA gene — a discovery that fundamentally revised the understanding of mitochondria from passive energy factories to active signalling organs.

MOTS-c activates AMPK through inhibition of folate-dependent one-carbon metabolism, leading to AICAR accumulation. This represents a retrograde communication pathway from mitochondria to the nucleus that coordinates cellular metabolic responses to mitochondrial status.

Critically for longevity research, circulating MOTS-c concentrations decline with age in both animal models and human studies, and Reynolds et al. (Nature Communications, 2021) identified MOTS-c as an exercise-induced mitokine in skeletal muscle — connecting it to the metabolic benefits of physical activity.

Research tool: MOTS-c

SS-31 (Elamipretide): Mitochondrial Membrane Research

SS-31 targets cardiolipin — a phospholipid unique to the inner mitochondrial membrane that is essential for electron transport chain supercomplex assembly and cytochrome c anchoring. Cardiolipin composition and integrity deteriorate with age, and this deterioration has been associated with declining mitochondrial bioenergetic capacity in aged tissues.

A key research advantage of SS-31 is that it concentrates in the inner mitochondrial membrane independently of membrane potential — meaning it can access depolarised mitochondria as found in aged cells and in ischaemia models. Szeto (British Journal of Pharmacology, 2014) established the cardiolipin interaction as the primary mechanism.

Research tool: SS-31 (Elamipretide)

GHK-Cu: Plasma Levels and Gene Regulation

Plasma GHK tripeptide levels are estimated at 200 ng/mL in young adults, declining to approximately 80 ng/mL by age 60 — a decline of 60% that coincides with well-documented changes in skin structure, wound healing capacity, and tissue maintenance.

GHK-Cu research published by Pickart and Margolina (IJMS, 2018) using microarray approaches in fibroblast models found that GHK-Cu treatment was associated with altered expression of genes involved in collagen synthesis, matrix metalloproteinase regulation, antioxidant defence, and anti-inflammatory signalling. The breadth of gene expression changes observed in these studies — affecting hundreds of genes — has made GHK-Cu one of the more intriguing research tools in longevity biology.

Research tool: GHK-Cu

FOXO4-DRI: Senescent Cell Research

Cellular senescence — stable cell cycle arrest accompanied by the senescence-associated secretory phenotype (SASP) — is now recognised as a driver of age-related tissue dysfunction. Senescent cells accumulate with age and secrete pro-inflammatory cytokines, matrix metalloproteinases, and growth factors that disrupt tissue homeostasis.

FOXO4-DRI interferes with the FOXO4-p53 protein interaction that has been identified as a survival mechanism enabling senescent cells to resist apoptosis. Baar et al. (Cell, 2017) published the seminal research demonstrating that disrupting this interaction in mouse models reduced senescence markers and SASP factor secretion.

Research tool: FOXO4-DRI

SLU-PP-332 and ERR Agonism

ERRalpha — activated by SLU-PP-332 — drives PGC-1alpha-mediated mitochondrial biogenesis. Since mitochondrial number and function decline with age, ERR agonism represents a potential approach to restoring mitochondrial biogenesis via a nuclear receptor pathway upstream of mitochondrial gene expression. The connection to NAD+ biology is direct: SIRT1, which deacetylates and activates PGC-1alpha, requires NAD+ as a co-substrate.

Research tool: SLU-PP-332

Published Research References

For laboratory and analytical research purposes only. Not for human or veterinary use. No dosage or administration guidance is provided or implied.

NAD+ | MOTS-c | SS-31 | GHK-Cu | FOXO4-DRI

NAD+ Decline: The Central Ageing Mechanism

NAD+ decline with age represents one of the most consistently documented biochemical changes in ageing across species. Verdin's landmark Science review (2015) synthesised the evidence across multiple model organisms: NAD+ concentrations in skeletal muscle, brain, liver, and skin decline approximately 50% between young adult and aged animals in rodent models, and similar declines have been documented in human cross-sectional studies.

The molecular drivers of this decline include: increased CD38 expression with age and inflammation (CD38 is a major NAD+ hydrolase that converts NAD+ to ADP-ribose and nicotinamide), increased PARP activation due to accumulating DNA damage (consuming NAD+ for poly-ADP-ribosylation reactions), and potentially decreased NAMPT expression in some tissues reducing NAD+ salvage pathway efficiency.

For research laboratories examining NAD+ in ageing contexts, the Signal Labs NAD+ research compound enables: direct measurement of NAD+ effects on sirtuin activity (SIRT1-SIRT7 deacetylase assays), study of the NAMPT-NMN-NAD+ salvage pathway kinetics, comparison of NAD+ supplementation with NNMT inhibition (5-Amino-1MQ) as complementary strategies for raising intracellular NAD+, and characterisation of CD38-mediated NAD+ consumption as a target for the age-related NAD+ decline.

Telomere Biology and Epithalon

The connection between cellular senescence (FOXO4-DRI research), telomere shortening (Epithalon research), and NAD+-dependent SIRT6 activity creates a mechanistic web linking multiple longevity peptide research tools:

SIRT6 (a NAD+-dependent deacylase) localises to telomeres where it maintains chromatin structure by deacetylating H3K9 and H3K56 — modifications that protect telomeric DNA from replication stress-induced damage. Age-related NAD+ decline reduces SIRT6 activity, contributing to telomere dysfunction and the resulting genomic instability that drives cellular senescence.

Epithalon's published effect on telomerase activation (Khavinson et al., 2003) addresses a different aspect of telomere biology: elongating telomeres rather than protecting them from damage. Using NAD+ (to support SIRT6-mediated telomere protection) and Epithalon (to examine telomerase-mediated telomere elongation) together in research provides complementary coverage of telomere maintenance biology from protection and extension perspectives simultaneously.

Frequently Asked Questions

How do longevity peptides differ from caloric restriction mimetics as research tools?
Caloric restriction (CR) mimetics — compounds like rapamycin (mTOR inhibitor), metformin (AMPK activator), and resveratrol (SIRT1 activator) — attempt to replicate the broad metabolic effects of caloric restriction. Longevity peptides like MOTS-c, NAD+, SS-31, and FOXO4-DRI target more specific mechanisms: mitochondrial signalling, energy sensor activation, cardiolipin protection, and senescent cell biology respectively. This specificity makes longevity peptides more useful as research tools for mechanistic dissection, where attributing effects to defined pathways is the goal, while CR mimetics are more relevant for studying the integrated response to energy restriction.

Is there published evidence that any of these compounds extend lifespan in animal models?
Published lifespan studies exist for several compounds in this category: Epithalon treatment has been reported to extend lifespan in Drosophila and mouse models in Russian-language publications by Khavinson's group. NAD+ precursor supplementation (NMN, NR) has been reported to improve healthspan metrics in aged mice in multiple published studies, though lifespan extension data is less consistent. FOXO4-DRI reduced senescent cell burden and improved physical function in published mouse studies by Baar et al. (Cell, 2017). These published datasets provide research context for Signal Labs compounds used in laboratory studies.

Browse all Signal Labs research peptides | Peptide storage guide | Reconstitution guide